BRIEF published on 12/11/2025 at 07:05, 8 days 13 hours ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
BRIEF published on 12/11/2025 at 07:05, 8 days 13 hours ago Innate Pharma révèle son calendrier financier 2026 Biotechnologie Calendrier Financier Immunothérapie Innate Pharma Résultats 2026
BRIEF published on 12/11/2025 at 07:05, 8 days 13 hours ago Innate Pharma annonce son calendrier financier pour 2026 Biotechnologie Calendrier Financier Informations Pour Les Investisseurs Innate Pharma Dates Clés De 2026
BRIEF published on 12/11/2025 at 07:05, 8 days 13 hours ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 8 days 13 hours ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
PRESS RELEASE published on 12/11/2025 at 07:00, 8 days 13 hours ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 21 days 13 hours ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/28/2025 at 07:05, 21 days 13 hours ago Nouveau nombre d'actions et droits de vote d'Innate Pharma Euronext Paris Capital Social Nasdaq Innate Pharma Actions Et Droits
PRESS RELEASE published on 11/28/2025 at 07:00, 21 days 13 hours ago Informations privilégiées / Autres communiqués Innate Pharma communique le nouveau nombre d'actions et de droits de vote au 27 novembre 2025 selon la réglementation en vigueur avec 92 196 523 actions ordinaires et 92 962 943 droits de vote théoriques Droits De Vote Actions AMF Innate Pharma Biotechnologies
BRIEF published on 11/17/2025 at 07:05, 1 month 2 days ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
Published on 12/19/2025 at 18:30, 1 hour 43 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 5 hours 33 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 6 hours 43 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 6 hours 43 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 6 hours 43 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 19:56, 16 minutes ago Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
Published on 12/19/2025 at 19:00, 1 hour 13 minutes ago HIAG sells sites and properties as part of its sharpened corporate strategy and gains Swiss Post as a new tenant in Winterthur
Published on 12/19/2025 at 18:29, 1 hour 43 minutes ago clearvise AG commissions Triticum agri-photovoltaic project
Published on 12/19/2025 at 18:29, 1 hour 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/19/2025 at 08:30, 11 hours 43 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 11 hours 43 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 13 hours 13 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 13 hours 13 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 1 day 1 hour ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
